Switch to:
GuruFocus articles
Headlines from internet
Oct-19-17$12.46 (+0.52%)
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
12:18AMJ And J Unattractive Seekingalpha
Oct-18-17$12.39 (-3.28%)
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
03:58PMADP Chief Calls Ackman's Proxy Fight a Distraction From Plan Bloomberg
03:36AMAllergan Pharma Darling Faces Uncertainty Seekingalpha
Oct-13-17$13.39 (-3.18%)
02:01PMValeant Reports Positive Results on Psoriasis Drug Siliq Zacks
12:56PMWhy Valeant is Dropping? Barron's
Oct-11-17$14.29 (-1.18%)
06:33PMAckman's Chipotle, Valeant Failures Give ADP Holders Pause; NAFTA in Focus-ICYMI theStreet
11:31AMEarnings Preview Valeant Pharmaceuticals Seekingalpha
Oct-10-17$14.46 (+0.28%)
08:45PMAckman Tells ADP Retail Investors That Their Vote Matters theStreet
Oct-05-17$14.57 (+1.32%)
12:30PMTime Trust Gilead Seekingalpha
Oct-03-17$14.36 (-1.78%)
03:24PMInova Multiples Unimpressive Uncertainty Persists Valeant Seekingalpha
02:03PMValeant: Still Deep in Junk Territory Barron's
11:19AMValeant: Still Deep in Junk Territory Barron's
Oct-02-17$14.62 (+2.02%)
11:01AMValeant Paying Debts Seekingalpha
04:31AMValeant Warned Seekingalpha
Sep-29-17$14.33 (+4.14%)
01:01PMDebt Worries Dog Specialty Pharma Barron's
12:23PMValeant: Opportunity Time? Barron's
Sep-28-17$13.76 (-4.38%)
11:19AMWhy Valeant is Sinking Barron's
Sep-26-17$14.1 (+0.07%)
06:44AMCenturylinks Yield Red Flag Cramers Lightning Round 9 25 17 Seekingalpha
Sep-20-17$14.07 (+2.18%)
01:16PMLeft Citron Boy Cried Wolf Seekingalpha
Sep-19-17$13.77 (-0.15%)
09:05AMAccounting Adjustments Contribute Alpha Generation Seekingalpha
Sep-18-17$13.79 (-0.93%)
01:07PMTeva 1_1 Billion Asset Sale Much Ado Nothing Seekingalpha
Sep-12-17$14.43 (+1.69%)
01:45PMValeant Run Catalysts Seekingalpha
Sep-11-17$14.19 (+4.26%)
08:54AMCooper Companies Still Comes Valuation Seekingalpha
Sep-01-17$13.33 (-0.67%)
03:43PMValeant: A Clear Sell Seekingalpha
06:27AMStock Exchange: Biggest Cause Of Trading Failure Seekingalpha
Aug-29-17$13.24 (-6.96%)
04:42PMValeant: Headline Risk Vs. Fundamentals Seekingalpha
Aug-28-17$14.23 (+0.64%)
11:00AM3 Things You Need To Know As Valeant Gets Sued For $80 Billion Seekingalpha
Aug-25-17$14.14 (-4.14%)
07:38PMWhy Pershing Square's ADP Thesis Should Be Taken Seriously Seekingalpha
03:15PMValeant: The Long or Short of It Barron's
11:47AMLord, Abbett Sues Valeant; Claims $80 Billion In Losses Seekingalpha
Aug-23-17$14.42 (+0.49%)
12:06PMValeant Looks Good Post-Q2 Seekingalpha
Aug-18-17$14.39 (+0.35%)
03:42PMValeant Pharmaceuticals International, Inc. 2017 Q2 - Results - Earnings Call Slides Seekingalpha
12:36PMBiotech Forum Daily Digest: What's Next For Adamas Pharmaceuticals? Seekingalpha
Aug-17-17$14.34 (+1.34%)
07:39AMThe Market Is Much More Than Just Washington - Cramer's Mad Money (8/16/17) Seekingalpha
Aug-15-17$13.9 (+0.94%)
12:55PMProgenics: Dynavax 2.0? Seekingalpha
Aug-14-17$13.77 (-0.86%)
01:59PMWill Teva Pharmaceuticals Bottom This Time? Seekingalpha
Aug-11-17$13.89 (+0.58%)
11:59AMValeant: Three Steps to a Recovery? Barron's
11:35AMValeant: Earnings Expose Problem Seekingalpha
10:02AMMallinckrodt's Demise Will Not Be Orderly Seekingalpha
Aug-10-17$13.81 (-1.85%)
01:44PMACADIA Reports Strong Earnings Resulting From Accounting Change Seekingalpha
12:32PMValeant: There's No Denying It Seekingalpha
10:13AMThere's A Reason Valeant Pharmaceuticals Bulls Didn't Stay Convinced Seekingalpha
02:20AMValeant Pharmaceuticals: A Lesson In Value Traps Seekingalpha
12:18AMValeant: Much More Upside Remains, Despite Messy Quarter Seekingalpha
Aug-09-17$14.07 (-10.04%)
03:01PMValeant: A Plausible Path Forward? Barron's
12:05PMValeant, 9 Months Later: The Countdown Continues Seekingalpha
06:59AMValeant Bonds Rise on Early Debt Repayment Barron's
Aug-08-17$15.64 (+1.76%)
01:36PMIs Teva The Next Valeant? Seekingalpha
11:47AMIs Now The Time To Buy Valeant Pharmaceuticals? Seekingalpha
Aug-07-17$15.37 (+1.59%)
09:22AMMylan Has No Where to Go But Up, Possible as High as the $70's Next Year Seekingalpha
Aug-05-17
03:37AMWhy Corporate Spinoffs For Shire And Valeant Make Sense Seekingalpha
Aug-04-17$15.13 (-2.07%)
05:28PMReminder: The Shkreli Verdict In No Way Fixes Price Gouging Seekingalpha
Aug-02-17$16.42 (-1.97%)
03:48PMThis Could Be The End Of Valeant Seekingalpha
Aug-01-17$16.75 (+1.76%)
10:25AMTough Competition For Valeant's Newly Approved Drug, SILIQ Seekingalpha
08:35AMLaunch Of SILIQ Makes Valeant A Great Short Opportunity Seekingalpha
Jul-31-17$16.46 (-2.26%)
12:52PMWhy Valeant Doubled From Its Recent Lows, And Why It Might Double Again Seekingalpha
Jul-24-17$17.54 (+0.23%)
03:36PMQ2 Earnings Should Be The Catalyst For Valeant's Next Leg Higher Seekingalpha
11:20AMFragile Vs. Antifragile: You Have To Understand What You're Dealing With First Seekingalpha
Jul-20-17$17.6 (+2.03%)
05:02PMMannKind - Afrezza Television Ad Debuts - What Investors Need To Know Seekingalpha
07:55AMHunting And Profiting From 'Fat Tails' - Be Long HighVol Assets Seekingalpha
Jul-19-17$17.25 (+0.52%)
08:28AMValeant Pharmaceuticals: Becoming A Better Buy? Seekingalpha
Jul-18-17$17.16 (-1.21%)
09:34AMJohnson & Johnson's Tremfya: A Potential Blockbuster Drug Seekingalpha
08:58AMEarnings Preview: Valeant Pharmaceuticals Seekingalpha
08:45AMThe Cooper Companies: $250 Looks Stretched Seekingalpha
Jul-17-17$17.37 (+0.75%)
04:57PMValeant: At Worst, A Good Catalyst Play Seekingalpha
03:38PMThe Good And Bad About The Obagi Sale Seekingalpha
03:00PMJohnson & Johnson: Approval Of TREMFYA Is Huge Win For Shareholders Seekingalpha
11:59AMBiotech Forum Daily Digest: Why Progenics Could Rally This Summer Seekingalpha
Jul-14-17$17.24 (-0.29%)
11:54AMValeant Pharmaceuticals Is Likely To Beat Earnings Seekingalpha
Jul-13-17$17.29 (+1.77%)
12:12PMValeant: Much More Upside Remains Part II Seekingalpha
Jul-12-17$16.99 (+2.53%)
02:01PMValeant: Much More Upside Remains Seekingalpha
Jul-11-17$16.57 (-0.54%)
01:33PMValeant Pharmaceuticals: Initiating Coverage With Buy Rating And Price Target = $32 Seekingalpha
Jul-07-17$16.23 (-2.23%)
12:45PMValeant: Why JPMorgan Is Asking Fundamentally The Wrong Question Seekingalpha
Jul-03-17$16.97 (-1.91%)
09:22AMValeant Has More Time, And Flexibility, Than You Might Think Seekingalpha
Jul-02-17
12:30AMValeant Has Topped Out For Now: A Simple Analysis Seekingalpha
Jun-30-17$17.3 (-0.06%)
11:06AM#Valeant After Ackman: Paulson Logs 26% Gain Barron's
Jun-27-17$16.65 (-2.52%)
12:42PMCAR-T Value Calculation In The Firing Line Seekingalpha
Jun-20-17$13.15 (-2.38%)
05:01PMValeant: Let's Talk Pipeline And Value Seekingalpha
01:16PMValeant: Is This Time Different? Seekingalpha
12:54PMYes, #Valeant is Rising But… Barron's
Jun-19-17$13.47 (+6.4%)
12:14PMCan John Paulson Revive #Valeant? Barron's
May-16-17$14.08 (-0.64%)
12:13PM3 Things In Biotech You Should Learn Today: May 16, 2017 Seekingalpha
12:13AMValeant: Overbought And Overvalued Seekingalpha
May-15-17$14.17 (+4.27%)
10:46AMValeant's Q1 - Key Bullish And Bearish Takeaways Seekingalpha
09:09AM5 More Reasons Valeant Pharmaceuticals Bottomed Seekingalpha
May-12-17$13.59 (-1.52%)
08:53AMValeant: More Debt Than Enterprise Value Seekingalpha
May-11-17$13.8 (+8.83%)
03:57PM#Valeant: ‘Hold the Applause,’ says Gimme Credit Barron's
12:29PMValeant Pharmaceuticals: Feeling Sentimental? Barron's
10:26AMValeant: 6 Months Later Seekingalpha
May-10-17$12.68 (+5.23%)
04:21PMThe Crux Of Valeant Pharmaceuticals' First Quarter In 4 Pictures Seekingalpha
01:51PMValeant: The Market Has Spoken Seekingalpha
12:26PMValeant's Story Is Changing Seekingalpha
12:16AMValeant: One-Time Tax Benefit = Better Earnings Optic Seekingalpha
May-09-17$12.05 (+24.1%)
04:44PMTouring The Top Market News Seekingalpha
08:45AMValeant Pharmaceuticals International, Inc. 2017 Q1 - Results - Earnings Call Slides Seekingalpha
12:13AMValeant Can Beat Earnings Seekingalpha
May-08-17$9.71 (-3.57%)
11:02PMValeant: Huge Legal Risk Seekingalpha
May-07-17
04:34PMValeant: Disappointing Earnings? Seekingalpha
May-06-17
03:43PMEarnings Preview: Valeant Pharmaceuticals Seekingalpha
07:21AMEarnings Will Crash Valeant Seekingalpha
May-05-17$10.07 (+2.34%)
01:52PMAvoid Mallinckrodt Into Earnings Seekingalpha
09:32AMWill Perrigo Collapse? Seekingalpha
09:11AMGenerics: The Divestiture That Can Save Valeant Seekingalpha
07:30AMNew Constructs Value Investing 2.0 - Exclusive Research From David Trainer Seekingalpha
May-04-17$9.84 (+0.41%)
05:44PMWhy Is It So Expensive To Grow Gilead? Seekingalpha
12:14PMValeant Management Tells The Future, If You Care To Listen Seekingalpha
May-03-17$9.8 (-4.95%)
09:43AMName Change: Signal Decoded Seekingalpha
07:55AMValeant: Still A Bad Investment Seekingalpha
May-02-17$10.31 (+6.73%)
10:20AMWhere Valeant Is Really Spending Its Money Seekingalpha
08:52AMValeant: Debt Situation Resolved Seekingalpha
May-01-17$9.66 (+4.43%)
11:43AMBuy Valeant Before Earnings? Seekingalpha
Apr-28-17$9.25 (-1.39%)
06:13PMObjective Review Of Valeant Seekingalpha
Apr-26-17$9.29 (+2.99%)
11:24PMIt's Time To Talk About Valeant Seekingalpha
08:02AMValeant Can Beat Guidance Seekingalpha
Apr-25-17$9.02 (+4.88%)
04:35PMValeant's Dermatology Division Is Doomed Seekingalpha
10:28AMValeant: The Math Doesn't Add Up Seekingalpha
06:18AMSouthwest Airlines Is Favorite - Cramer's Lightning Round (4/24/2017) Seekingalpha
Apr-24-17$8.6 (+1.06%)
04:00PMValeant Pharmaceuticals Is An Asset Play And Any Growth Is A Margin Of Safety Seekingalpha
Apr-23-17
11:12PMValeant Pharmaceuticals Nearing Capitulation, Breaks $8.50 Seekingalpha
10:48PMValeant Is Unfairly Undervalued II Seekingalpha
Apr-21-17$8.51 (-4.17%)
01:28PMValeant Pharmaceuticals: Not Worth the Risk! Barron's
12:27PMFiling Season Finds: 10-K Filing Season Recap Seekingalpha
12:07PMValeant: What Went Wrong? Seekingalpha
Apr-20-17$8.88 (-1.55%)
01:58AMValeant: Heading To Penny Stock Status? Seekingalpha
Apr-19-17$9.02 (+0.78%)
03:10AMBill Ackman's Stock Portfolio: Every Holding Analyzed Seekingalpha
Apr-18-17$8.95 (-5.59%)
02:37PMValeant: Collapse Imminent Seekingalpha
02:00PMFrontier Communications: Memories Of Valeant Seekingalpha
Apr-17-17$9.48 (+0%)
03:17PMValeant Selloff Justified, But Is A Turnaround In Distant Sight? Seekingalpha
01:37PMProgenics Pharmaceuticals: Is It Time To Buy? Seekingalpha
Apr-15-17
08:49PMValeant Will Bounce Back To $10 Seekingalpha
Apr-14-17$9.48 (+0%)
09:16AMValeant's Growth Drivers Fail Seekingalpha
Apr-13-17$9.48 (-1.25%)
04:09PMValeant Is Unfairly Overvalued Seekingalpha
Apr-11-17$9.55 (-3.05%)
04:09PMValeant Is Unfairly Undervalued Seekingalpha
12:14PMValeant Would Be A Bad Acquisition Seekingalpha
Apr-10-17$9.85 (+2.71%)
07:17AMDon't Bet Against Don Wood - Cramer's Lightning Round (4/7/2017) Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK